CoChat

The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index; 8 of the 23 sources its claims cite were checked for support.

Mechanisms of postprandial glucose counterregulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestion

Open access
Tse, T F, Clutter, W E, Shah, S D, Cryer, P E · 1983 · Journal of Clinical Investigation

Abstract

The transition from exogenous glucose delivery to endogenous glucose production late after glucose ingestion is not solely attributable to dissipation of insulin and, therefore, must also involve factors that actively raise the plasma glucose concentration--glucose counterregulatory factors. We have shown that the secretion of two of these, glucagon and epinephrine, is specific for glucose ingestion and temporally related to the glucose counterregulatory process. To determine the physiologic roles of glucagon and epinephrine in postprandial glucose counterregulation, we produced pharmacologic interventions that resulted in endogenous glucagon deficiency with and without exogenous glucagon replacement, adrenergic blockade, and adrenergic blockade coupled with glucagon deficiency starting 225 min after the ingestion of 75 g of glucose in normal subjects. Also, we assessed the effect of endogenous epinephrine deficiency alone and in combination with glucagon deficiency late after glucose ingestion in bilaterally adrenalectomized subjects. Glucagon deficiency resulted in nadir plasma glucose concentrations that were approximately 30% lower (P less than 0.01) than control values, but did not cause hypoglycemia late after glucose ingestion. This effect was prevented by glucagon replacement. Neither adrenergic blockade nor epinephrine deficiency alone impaired the glucose counterregulatory process. However, combined glucagon and epinephrine deficiencies resulted in a progressive fall in mean plasma glucose to a hypoglycemic level late after glucose ingestion; the final glucose concentration was 40% lower (P less than 0.02) than the control (epinephrine deficient) value in these patients, and was nearly 50% lower (P less than 0.001) than the control value and approximately 30% lower (P less than 0.05) than the glucagon-deficient value in normal subjects. We conclude (a) the transition from exogenous glucose delivery to endogenous glucose production late after glucose ingestion is the result of the coordinated diminution of insulin secretion and the resumption of glucagon secretion. (b) Epinephrine does not normally play a critical role in this process, but enhanced epinephrine secretion compensates largely and prevents hypoglycemia when glucagon secretion is deficient.

Overview

CoChat Summary

TL;DR

In normal and bilaterally adrenalectomized humans, glucagon deficiency late after oral glucose lowered plasma glucose but did not cause hypoglycemia unless epinephrine was also deficient. The transition from exogenous glucose delivery to endogenous glucose production after glucose ingestion depends on coordinated insulin diminution and glucagon resumption, with epinephrine compensating when glucagon is deficient.

Key findings

Glucagon deficiency (somatostatin plus insulin replacement) lowered nadir plasma glucose to 62±3 mg/dl at 275 min versus 85±6 mg/dl during saline (P < 0.01), about 30% lower, and this was prevented by glucagon replacement. Neither combined α/β-adrenergic blockade nor epinephrine deficiency alone impaired late postprandial glucose counterregulation. Combined glucagon and epinephrine deficiency caused progressive hypoglycemia: in adrenalectomized patients, final glucose was 47±9 mg/dl at 305 min versus 78±10 mg/dl with saline (P < 0.02), 88±4 mg/dl in normal saline controls (P < 0.001), and 68±3 mg/dl in glucagon-deficient normal subjects (P < 0.05). The authors conclude epinephrine is not normally critical but compensates largely and prevents hypoglycemia when glucagon secretion is deficient.

Methods

Eight normal adults (7 male, 1 female; ages 23–28 yr) and five bilaterally adrenalectomized patients (2 male, 3 female; ages 24–57 yr) with deficient epinephrine response to insulin-induced hypoglycemia ingested 75 g glucose after an overnight fast. Interventions began 225–305 min after glucose: saline; somatostatin (250 μg/h) with insulin replacement (100 μU/kg/min); somatostatin plus insulin plus glucagon replacement (1.0 or 1.5 ng/kg/min); phentolamine plus propranolol; and phentolamine-propranolol plus somatostatin with insulin replacement in normal subjects; adrenalectomized patients received saline or somatostatin with insulin replacement. Plasma glucose, insulin, glucagon, epinephrine, norepinephrine, cortisol, and growth hormone were measured, with paired or unpaired t tests and P < 0.05 considered significant.

Limitations

Stated: phentolamine and propranolol are competitive antagonists that markedly elevate plasma catecholamines, so negative findings must be interpreted cautiously and positive findings may underestimate normal adrenergic effects; somatostatin produced only small decreases in measured immunoreactive glucagon, and peripheral venous glucagon may not reflect biologically active portal glucagon. Stated: the adrenalectomized patients were not matched to normal subjects, had baseline and post-glucose hyperinsulinemia probably due to obesity, and one patient’s study was discontinued for neuroglycopenia with the 35 mg/dl value carried forward, likely making the final mean lower had the study continued. Stated: the study addresses rapid glucose counterregulation, and mechanisms of more gradual counterregulation may differ; other hormones, neural mechanisms, or autoregulation are not excluded.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1172/jci110967

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

7 Valid · 1 Not valid · 6 Not checked · 41 Own results and interpretations

34 more claims

Create a free account to see all 55 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 11
  • Probably not a substantial claim. 6

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 25 references

Cited by

See all 73

Metadata

Authors
Tse, T. F., Clutter, W. E., Shah, S. D., & Cryer, P. E.
Affiliations
Washington University in St. Louis (US)
Venue
Journal of Clinical Investigation
Published
1983-07-01
Volume
72
Issue
1
Pages
278-286
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2012300813
Cited by
73
References
25
Citations by year
2021: 1 · 2017: 1 · 2016: 2 · 2014: 1 · 2013: 1
FWCI
6.65
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
glucagon, epinephrine, insulin, hypoglycemia, glucagon deficiency, adrenergic blockade, adrenalectomy, endogenous glucose production, plasma glucose
MeSH terms
Adrenalectomy, Adult, Blood Glucose, Epinephrine, Female, Glucagon, Glucose, Humans, Insulin, Male, Phentolamine, Propranolol, Somatostatin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mechanisms of postprandial glucose counterregulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestion. https://app.cochat.ai/papers/10.1172/jci110967
The paper
Tse, T. F., Clutter, W. E., Shah, S. D., & Cryer, P. E. (1983). Mechanisms of postprandial glucose counterregulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestion. Journal of Clinical Investigation. https://doi.org/10.1172/jci110967

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.